Why are some drug launches successful and some aren’t?
The launch of a new drug is a complex process. With so many factors playing into the final outcome, it may seem impossible to predict whether or not any given launch will be a success. While it’s true [...]
6 Examples of When Competitive Intelligence Should Be a Top Priority
The pharma industry can be complicated, but the more intel you have – market or competitive, the better you’ll be able to make decisions that lead you to success. Understanding what’s worked for your competitors, what hasn’t, where [...]
5 Key Takeaways When Launching a New Drug
For those launching their first product, the process can be incredibly daunting – but if you know what to look for, both the successes and the failures can help guide your launch strategy. With over 215+ new [...]
New White Paper: Pathways of Care, Shifting Financial Risk and Value Frameworks – Where is the Oncology Market Heading?
Historically, the management of oncology drugs in the U.S. has remained relatively hands-off, despite high budget impact. However, the situation may be changing. Recently, there has been discussion around new management tools, shifting of financial risk, and the [...]
Why Manufacturers Launching Specialty Drugs Need Trade Management
Launching a drug isn’t easy. All manufacturers, no matter the classification of product they create, face challenges on the journey to bring their drug to market. However, due to the nature of their dose form, complex storage needs, [...]
Jack Ericsson Joins Two Labs as Business Development Director
At Two Labs, we know that our clients are looking for solutions. Every service we offer is about paving the way for our clients to launch their products to the market and into the hands of patients who [...]